Abstract
Background
Women with polycystic ovary syndrome (PCO) suffer from psychological difficulties like bipolar disorder.
Various studies in the literature report several prevalence rates of bipolar disorder in women with PCO, while there is no systematic review in this field. So, we designed this systematic review and meta-analysis to estimate the pooled prevalence and odds of bipolar disorder in women with PCO disease.
Method
PubMed, Scopus, EMBASE, Web of Science, Google Scholar, and references of the references, conference abstracts were comprehensively searched by two independent researchers. The search was done on May 1st, 2023.
Results
A literature search revealed 438 records, 35 full texts were evaluated, and finally, 11 studies remained for systematic review. Totally, 73,102 women with PCO and 340,724 controls were evaluated. Among cases, 1471 had bipolar diagnosis vs. 4321 controls. The prevalence of bipolar disorder in women with PCO ranged between 0 and 27%, and the pooled prevalence was estimated as 4% (95% CI, 2–5%; I2, 99.3%, p < 0.001). The odds of bipolar disorder in women with PCO ranged between 0.98 and 8.78, and the pooled estimate was 2.06 (95% CI, 1.61–2.63) (I2, 85.6%; p < 0.001).
Conclusions
This systematic review and meta-analysis show that the pooled prevalence of bipolar disorder in women with PCO is 4%, and women with PCO are at a 2-fold higher risk of bipolar disorder.
Similar content being viewed by others
References
Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–2749
Berni TR, Morgan CL, Berni ER, Rees DA (2018) Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes. J Clin Endocrinol Metab 103(6):2116–2125
Cesta CE, Månsson M, Palm C, Lichtenstein P, Iliadou AN, Landén M (2016) Polycystic ovary syndrome and psychiatric disorders: co-morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology 73:196–203
Chen S-F, Yang Y-C, Hsu C-Y, Shen Y-C (2020) Risk of bipolar disorder in patients with polycystic ovary syndrome: a nationwide population-based cohort study. J Affect Disord 263:458–462
Dai W, Liu J, Qiu Y, Teng Z, Li S, Huang J et al (2022) Shared postulations between bipolar disorder and polycystic ovary syndrome pathologies. Prog Neuropsychopharmacol Biol Psychiatry 115:110498
Davari-Tanha F, Rashidi BH, Ghajarzadeh M, Noorbala AA (2014) Bipolar disorder in women with polycystic ovarian syndrome (PCO). Acta Med Iran 52(1):46–48
Eggers S, Kirchengast S (2001) The polycystic ovary syndrome–a medical condition but also an important psychosocial problem. Coll Antropol 25(2):673–685
Elsenbruch S, Hahn S, Kowalsky D, Öffner AH, Schedlowski M, Mann K et al (2003) Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88(12):5801–5807
Fornaro M, Iovieno N, Clementi N, Boscaro M, Paggi F, Balercia G et al (2010) Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders. World J Biol Psychiatry 11(8):991–996
Glintborg D, Hass Rubin K, Nybo M, Abrahamsen B, Andersen M (2015) Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome. Eur J Endocrinol 172(5):627–638
Glueck CJ, Goldenberg N (2019) Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism 92:108–120
Goldstein BI, Liu SM, Zivkovic N, Schaffer A, Chien LC, Blanco C (2011) The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord 13(4):387–395
Grande I, Berk M, Birmaher B, Vieta E (2016) Bipolar disorder. Lancet 387(10027):1561–1572
Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M et al (2005) Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 153(6):853–860
Hung J-H, Hu L-Y, Tsai S-J, Yang AC, Huang M-W, Chen P-M et al (2014) Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS ONE 9(5):e97041
Klipstein KG, Goldberg JF (2006) Screening for bipolar disorder in women with polycystic ovary syndrome: a pilot study. J Affect Disord 91(2–3):205–209
Lv Y-B, Wang Y, Ma W-G, Yan D-Y, Zheng W-L, Chu C et al (2016) Association of renalase SNPs rs2296545 and rs2576178 with the risk of hypertension: a meta-analysis. PLoS ONE 11(7):e0158880
Manteghi G, Shahraki Z, Moghadam MN, Ghanbarpour MH (2021) Pregnancy outcome in PCOS patients: the effects of letrozol combined with exercise. J Klin Endokrinol Stoffwechsel 14(3):128–132
Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S et al (2016) Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS ONE 11(1):e0147601
Mojahed BS, Ghajarzadeh M, Khammar R, Shahraki Z (2023) Depression, sexual function and sexual quality of life in women with polycystic ovary syndrome (PCOS) and healthy subjects. J Ovarian Res 16(1):105
Nivoli AM, Pacchiarotti I, Rosa AR, Popovic D, Murru A, Valenti M et al (2011) Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J Affect Disord 133(3):443–449
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906
Pan J-X, Tan Y-J, Wang F-F, Hou N-N, Xiang Y-Q, Zhang J-Y et al (2018) Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis. Clin Epigenetics 10:1–12
Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, Bruno RV et al (2010) Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry 51(6):599–602
Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, Głowińska A, Spaczyński R, Rybakowski F et al (2019) Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr Pol 53(4):955–966
Sahingöz M, Uguz F, Gezginc K, Korucu DG (2013) Axis I and Axis II diagnoses in women with PCOS. Gen Hosp Psychiatry 35(5):508–511
Sirmans SM, Parish RC, Blake S, Wang X (2014) Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population. J Investig Med 62(6):868–874
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605
Tay CT, Teede HJ, Loxton D, Kulkarni J, Joham AE (2020) Psychiatric comorbidities and adverse childhood experiences in women with self-reported polycystic ovary syndrome: an Australian population-based study. Psychoneuroendocrinology 116:104678
Walters KA, Gilchrist RB, Ledger WL, Teede HJ, Handelsman DJ, Campbell RE (2018) New perspectives on the pathogenesis of PCOS: neuroendocrine origins. Trends Endocrinol Metab 29(12):841–852
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shahraki, Z., Rastkar, M., Ramezanpour, MR. et al. The prevalence and odds of bipolar disorder in women with polycystic ovary syndrome (PCO) disease: a systematic review and meta-analysis. Arch Womens Ment Health (2024). https://doi.org/10.1007/s00737-024-01420-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00737-024-01420-w